Filing Details
- Accession Number:
- 0001127602-25-006251
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-21 16:38:37
- Reporting Period:
- 2025-02-20
- Filing Date:
- 2025-02-21
- Accepted Time:
- 2025-02-21 16:38:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1732091 | Birgit Girshick | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-20 | 1,514 | $164.63 | 55,058 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
